Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terv...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Paweł Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2023-04-01
Serier:	Children
Fag:	venetoclax ABT-199 BH3 mimetics acute lymphoblastic leukaemia acute myeloid leukaemia juvenile myelomonocytic leukaemia
Online adgang:	https://www.mdpi.com/2227-9067/10/4/745
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!